Myelin Basic Protein in Oligodendrocyte-Derived Extracellular Vesicles as a Diagnostic and Prognostic Biomarker in Multiple Sclerosis: A Pilot Study
Authors:
- Cristina AgliardiCACristina Agliardi
- Franca Rosa GueriniFGFranca Rosa Guerini
- Milena ZanzotteraMZMilena Zanzottera
- Elisabetta BolognesiEBElisabetta Bolognesi
- Silvia PiccioliniSPSilvia Picciolini
- Domenico CaputoDCDomenico Caputo
- Marco RovarisMRMarco Rovaris
- Maria Barbara PasanisiMPMaria Barbara Pasanisi
- Mario ClericiMario Clerici
Open Access
- 3 January 2023
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (1) , 894
Abstract
Approximately 15% of multiple sclerosis (MS) patients develop a progressive form of disease from onset; this condition (primary progressive-PP) MS is difficult to diagnose and treat, and is associated with a poor prognosis. Extracellular vesicles (EVs) of brain origin isolated from blood and their protein cargoes could function as a biomarker of pathological conditions. We verified whether MBP and MOG content in oligodendrocytes-derived EVs (ODEVs) could be biomarkers of MS and could help in the differential diagnosis of clinical MS phenotypes. A total of 136 individuals (7 clinically isolated syndrome (CIS), 18 PPMS, 49 relapsing remitting (RRMS)) and 70 matched healthy controls (HC) were enrolled. ODEVs were enriched from serum by immune-capture with anti-MOG antibody; MBP and MOG protein cargoes were measured by ELISA. MBP concentration in ODEVs was significantly increased in CIS (p < 0.001), RRMS (p < 0.001) and PPMS (p < 0.001) compared to HC and was correlated with disease severity measured by EDSS and MSSS. Notably, MBP concentration in ODEVs was also significantly augmented in PPMS compared to RRMS (p = 0.004) and CIS (p = 0.03). Logistic regression and ROC analyses confirmed these results. A minimally invasive blood test measuring the concentration of MBP in ODEVs is a promising tool that could facilitate MS diagnosis.Keywords
Funding Information
- Italian Ministry of Health
- Fondazione Alessandro e Vincenzo Negroni Prati Morosini
- Fondazione Romeo ed Enrica Invernizzi
This publication has 25 references indexed in Scilit:
- Cerebrospinal Fluid Myelin Basic Protein Is Frequently Ordered but Has Little ValueAmerican Journal of Clinical Pathology, 2012
- Receiver Operating Characteristic Curve in Diagnostic Test AssessmentJournal of Thoracic Oncology, 2010
- Rituximab in patients with primary progressive multiple sclerosis: Results of a randomized double‐blind placebo‐controlled multicenter trialAnnals of Neurology, 2009
- A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHCNature Genetics, 2006
- In vivo detection of myelin proteins in cervical lymph nodes of MS patients using ultrasound-guided fine-needle aspiration cytologyJournal of Neuroimmunology, 2005
- Isolation and characterization of autoreactive moteolioid protein‐peptide specific T‐cell clones from multiple sclerosis patientsNeurology, 1995
- Reactivity to myelin antigens in multiple sclerosis. Peripheral blood lymphocytes respond predominantly to myelin oligodendrocyte glycoprotein.Journal of Clinical Investigation, 1993
- The cellular and molecular events of central nervous system remyelinationBioEssays, 1990
- Rating neurologic impairment in multiple sclerosisNeurology, 1983
- THE ISOLATION FROM BOVINE SPINAL CORD OF A HOMOGENEOUS PROTEIN WITH ENCEPHALITOGENIC ACTIVITY*Journal of Neurochemistry, 1962